Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...
Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Philip Morris outperformed the S&P 500 in 2024, driven by strong financials, a 4.5% dividend yield, and consistent cash generation exceeding $10 billion annually. Despite regulatory risks ...